What is MaxCyte's net income?

MaxCyte (MXCT) reported net income of -$4.75M in Q1 2026.

How has MaxCyte's net income changed year-over-year?

MaxCyte's net income increased by 53.7% year-over-year, from -$10.26M to -$4.75M.

What is the long-term trend for MaxCyte's net income?

Over 4 years (2021 to 2025), MaxCyte's net income has grown at a 23.7% compound annual growth rate (CAGR), from -$19.08M to -$44.63M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

MaxCyte MXCT Net Income

Net Income at other companies

Thermo Fisher ScientificTMO

$1.65B+9.6%

Immix Biopharma, Inc.IMMX

-$10.09M-122%

Rapid Micro BiosystemsRPID

-$14.28M-26.7%

PDE

Pro-Dex, Inc.PDEX

$3.94M+20.2%

RepligenRGEN

$8.33M+42.9%

TEC

Bio-TechneTECH

$51.05M+126%

Segments

By segment

See full

Cell Engineering Technology-$4.75M+53.7%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's net income?: MaxCyte (MXCT) reported net income of -$4.75M in Q1 2026.
How has MaxCyte's net income changed year-over-year?: MaxCyte's net income increased by 53.7% year-over-year, from -$10.26M to -$4.75M.
What is the long-term trend for MaxCyte's net income?: Over 4 years (2021 to 2025), MaxCyte's net income has grown at a 23.7% compound annual growth rate (CAGR), from -$19.08M to -$44.63M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.